Want to join the conversation?
$AMGN will present new interim data from phase 2 trial provides further insight into Imlygic as potential combination partner with checkpoint inhibitor for patients with advanced melanoma skin cancer. Also, retrospective analyses of Vectibix combination regimen in metastatic colorectal cancer evaluate impact of tumor site of origin on efficacy.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.